9K48 | pdb_00009k48

Bacetrial Cocaine Esterase with mutations T172R/G173Q/V116K/S117A/A51K


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.25 Å
  • R-Value Free: 
    0.203 (Depositor), 0.204 (DCC) 
  • R-Value Work: 
    0.160 (Depositor), 0.161 (DCC) 
  • R-Value Observed: 
    0.163 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.0 of the entry. See complete history


Literature

Catalytic mechanism, computational design, and crystal structure of a highly specific and efficient benzoylecgonine hydrolase.

Chen, X.Zhang, Y.Tong, J.Ouyang, P.Deng, X.Zhang, J.Liu, H.Hu, Y.Yao, W.Wang, J.Wang, X.Hou, S.Yao, J.

(2024) Int J Biol Macromol 283: 137767-137767

  • DOI: https://doi.org/10.1016/j.ijbiomac.2024.137767
  • Primary Citation of Related Structures:  
    9K48

  • PubMed Abstract: 

    Enzyme therapy for cocaine detoxification should break down both cocaine and its primary toxic metabolite, benzoylecgonine (BZE), which is also the main form of cocaine contaminant in the environment. An ideal BZE-metabolizing enzyme (BZEase) is expected to be highly efficient and selective in BZE hydrolysis. Here, BZEase4 was engineered from bacterial cocaine esterase (CocE) by our reactant state-based enzyme design theories (RED), which has a 34,977-fold improved substrate discrimination between BZE and the neurotransmitter acetylcholine (ACh), compared with wild-type CocE. Under the physiological concentrations of BZE and ACh, the reaction velocity of BZEase4 against BZE is 2.25 × 10 6 -fold higher than it against ACh, suggesting BZEase4 has extremely high substrate selectivity for BZE over ACh to minimize the potential cholinergic side-effects. This study provides additional evidence supporting the further development of BZEase4 toward a promising therapeutic for cocaine overdose, a potentially effective and eco-friendly enzymatic method for BZE degradation in the environment.


  • Organizational Affiliation
    • School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China. Electronic address: xch226@hznu.edu.cn.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Cocaine esterase574Rhodococcus sp. MB1 'Bresler 1999Mutation(s): 5 
Gene Names: cocE
EC: 3.1.1.84
UniProt
Find proteins for Q9L9D7 (Rhodococcus sp. (strain MB1 Bresler))
Explore Q9L9D7 
Go to UniProtKB:  Q9L9D7
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ9L9D7
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.25 Å
  • R-Value Free:  0.203 (Depositor), 0.204 (DCC) 
  • R-Value Work:  0.160 (Depositor), 0.161 (DCC) 
  • R-Value Observed: 0.163 (Depositor) 
Space Group: P 65 2 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 105.959α = 90
b = 105.959β = 90
c = 221.997γ = 120
Software Package:
Software NamePurpose
PHENIXrefinement
HKL-3000data scaling
HKL-3000data reduction
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Natural Science Foundation of China (NSFC)China32101010
Ministry of Science and Technology (MoST, China)China2022ZD0214600

Revision History  (Full details and data files)

  • Version 1.0: 2024-12-18
    Type: Initial release